Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Moligand™, ≥98% Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Room temperature Ships Normal Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 11 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Product Describtion:
1-Methyl-4-phenylpyridinium (MPP+) induces neurotoxicity by inhibiting mitochondrial redox functions in the striatal synaptosomes. It is a potential neurotoxin and induces Parkinson′s disease in animal models. It mediates apoptosis by the generation of reactive oxygen species in cerebellar granule neurons and neuroblastoma cells. MPP+ modulates the distribution of dopamine. It elicits neurotoxicity by activating neuronal nitric oxide synthase (nNOS), resulting in excess nitric oxide.
Product Application: MPP+ iodide has been used: to induce oxidative stress in zebrafish embryos for the inhibition of glutamate uptake in mitochondria of astrocytes in testing cell viability using MTT (3 (4,5-dimethylthiazol)-2-yl-2,5-diphenyltetrazolium bromide) in microglia (BV2) cells
| Pubchem Sid | 504765742 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504765742 |
| Canonical Smiles | C[N+]1=CC=C(C=C1)C2=CC=CC=C2.[I-] |
| IUPAC Name | 1-methyl-4-phenylpyridin-1-ium;iodide |
| InChIKey | RFDFRDXIIKROAI-UHFFFAOYSA-M |
| INCHI | 1S/C12H12N.HI/c1-13-9-7-12(8-10-13)11-5-3-2-4-6-11;/h2-10H,1H3;1H/q+1;/p-1 |
| Isomeric SMILES | C[N+]1=CC=C(C=C1)C2=CC=CC=C2.[I-] |
| WGK Germany | 3 |
| RTECS | UU6580000 |
| PubChem CID | 10924457 |
| UN Number | 2811 |
| Packing Group | II |
| Molecular Weight | 297.13 |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organoheterocyclic compounds |
| Class | Pyridines and derivatives |
| Subclass | Phenylpyridines |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Phenylpyridines |
| Alternative Parents | N-methylpyridinium compounds Pyridinium derivatives Benzene and substituted derivatives Heteroaromatic compounds Azacyclic compounds Organonitrogen compounds Organic iodide salts Hydrocarbon derivatives Organic cations |
| Molecular Framework | Aromatic heteromonocyclic compounds |
| Substituents | 4-phenylpyridine - N-methylpyridinium - Benzenoid - Pyridinium - Monocyclic benzene moiety - Heteroaromatic compound - Azacycle - Organic nitrogen compound - Hydrocarbon derivative - Organic iodide salt - Organic salt - Organonitrogen compound - Organic cation - Aromatic heteromonocyclic compound |
| Description | This compound belongs to the class of organic compounds known as phenylpyridines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyridine ring through a CC or CN bond. |
| External Descriptors | Not available |
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Jun 10, 2026 | N137206 | |
| Certificate of Analysis | Mar 11, 2026 | N137206 | |
| Certificate of Analysis | Mar 07, 2026 | N137206 | |
| Certificate of Analysis | Mar 07, 2026 | N137206 | |
| Certificate of Analysis | Mar 07, 2026 | N137206 | |
| Certificate of Analysis | Mar 07, 2026 | N137206 | |
| Certificate of Analysis | Oct 11, 2025 | N137206 | |
| Certificate of Analysis | Aug 04, 2025 | N137206 | |
| Certificate of Analysis | Aug 04, 2025 | N137206 | |
| Certificate of Analysis | Aug 04, 2025 | N137206 | |
| Certificate of Analysis | Aug 04, 2025 | N137206 | |
| Certificate of Analysis | Jul 02, 2025 | N137206 | |
| Certificate of Analysis | Sep 18, 2024 | N137206 | |
| Certificate of Analysis | Sep 18, 2024 | N137206 | |
| Certificate of Analysis | Sep 18, 2024 | N137206 | |
| Certificate of Analysis | Sep 18, 2024 | N137206 | |
| Certificate of Analysis | Jan 04, 2024 | N137206 | |
| Certificate of Analysis | Sep 29, 2022 | N137206 | |
| Certificate of Analysis | Sep 29, 2022 | N137206 | |
| Certificate of Analysis | Sep 29, 2022 | N137206 | |
| Certificate of Analysis | Sep 29, 2022 | N137206 | |
| Certificate of Analysis | Jan 05, 2022 | N137206 | |
| Certificate of Analysis | Jan 05, 2022 | N137206 |
| Solubility | H2O: >10 mg/mL, soluble |
|---|---|
| Sensitivity | light & Moisture sensitive |
| Molecular Weight | 297.130 g/mol |
| XLogP3 | |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 1 |
| Exact Mass | 297.001 Da |
| Monoisotopic Mass | 297.001 Da |
| Topological Polar Surface Area | 3.900 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 141.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 2 |
| 1. Chao Guo, Junrong Zhu, Jingwen Wang, Jialin Duan, Shanbo Ma, Ying Yin, Wei Quan, Wei Zhang, Yue Guan, Yi Ding, Aidong Wen, Yingdong Zhang. (2019) Neuroprotective effects of protocatechuic aldehyde through PLK2/p-GSK3β/Nrf2 signaling pathway in both in vivo and in vitro models of Parkinson's disease. Aging-US, [PMID:31697645] [10.18632/aging.102394] |
| 2. Yun Yu, Xiu-Yuan Lang, Xi-Xi Li, Run-Ze Gu, Qing-Shan Liu, Rongfeng Lan, Xiao-Yan Qin. (2019) 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside attenuates MPP+/MPTP-induced neurotoxicity in vitro and in vivo by restoring the BDNF-TrkB and FGF2-Akt signaling axis and inhibition of apoptosis. Food & Function, 10 (9): (6009-6019). [PMID:31482900] [10.1039/C9FO01309A] |
| 3. Aijie Zhang, Shiqi Dong, Fanlong Yang, Yufeng Zhang, Yunhua Teng, Weisheng Tang, Jianfeng Liu, Huirong Fan, Ying Peng, Jiang Zheng. (2024) Effect of X-ray irradiation on renal excretion of bestatin through down-regulating organic anion transporters via the vitamin D receptor in rats. CHEMICO-BIOLOGICAL INTERACTIONS, [PMID:38964638] [10.1016/j.cbi.2024.111123] |
| 4. Qiang-Ming Li, Shu-Zhen Wu, Xue-Qiang Zha, Dan-Dan Zang, Feng-Yun Zhang, Jian-Ping Luo. (2024) Ganoderic acid A mitigates dopaminergic neuron ferroptosis via inhibiting NCOA4-mediated ferritinophagy in Parkinson’s disease mice. JOURNAL OF ETHNOPHARMACOLOGY, [PMID:38763373] [10.1016/j.jep.2024.118363] |
| 5. Cao Ting, Wang Xue-lian, Rao Jiang-yan, Zhu Hui-feng, Qi Hong-yi, Tian Zhen. (2024) Periplaneta americana L. extract exerts neuroprotective effects by inhibiting endoplasmic reticulum stress via AKT-dependent pathway in experimental models of Parkinson’s disease. Chinese Medicine, 19 (1): (1-24). [PMID:39538357] [10.1186/s13020-024-01029-2] |
| 6. Ao Sun, Yu-fei Li, Yang Miao, Hong-xia Wang, Lin-lin Zhang. (2024) Research on the mechanism of Ursolic acid for treating Parkinson's disease by network pharmacology and experimental verification. Heliyon, [PMID:39108896] [10.1016/j.heliyon.2024.e34113] |
| 7. Wengui Lu, Chuan Zhang, Yaru Zhang, Ru Xiao, Chaoqi Wei, Fan Zhang, Zhenbao Li, Hewan Xia, Mimi Wan, Zhifei Cheng, Qi Wang. (2025) A programmed Ca2+ nanomodulator by dynamically regulating autophagy and neuroinflammation for Parkinson's disease therapy. CHEMICAL ENGINEERING JOURNAL, [PMID:] [10.1016/j.cej.2025.166324] |
| 8. Yujun Chen, Yuhang Zhao, Qing Wang, Qiuchi Chen, Xiqun Chen, Kai Yang. (2025) Exploratory Study on the Role of Emodin in Alleviating MPTP-Induced Neurotoxicity: A Focus on p53-Ferroptosis Signaling. Drug Design Development and Therapy, [PMID:41356603] [10.2147/DDDT.S522381] |
| 9. Wenqian Wang, Qingfu Zhang, Tong Zhang, Fuping Lu, Fufeng Liu. (2025) Ulva polysaccharide alleviates Parkinson's disease by regulating inflammation, oxidative damage, and gut microbiota. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, [PMID:41468939] [10.1016/j.ijbiomac.2025.149946] |
| 10. Chunlian Liu, Siwen Wang, Haifan Yu, Kai Duo, Chunyu Wang, Jing Jiang, Lin Li. (2026) RVG29-Decorated PLGA/Piperine Nanoparticles for Treating Parkinson’s Disease via Restoring Neuronal Energy Metabolism. ACS Applied Nano Materials, [PMID:] [10.1021/acsanm.5c05528] |
| 11. Wenyu Xie, Ke Wu, Lin Zhang, Xiyu Feng, Shangshen Yang, Siyu Jia, Yutong Li, Xiaoming Wang. (2026) The H2S donor sulforaphane inhibits NLRP3 inflammasome activation by inducing mitochondrial autophagy and mitigating CBS-H2S axis damage in in-vitro and in-vivo models of Parkinson's disease. BIOORGANIC CHEMISTRY, [PMID:] [10.1016/j.bioorg.2026.109708] |
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Moligand™ grade guide →